The findings of this study suggest that a higher level of tumor AR protein is positively associated with a better overall survival in cutaneous melanoma patients, which remains true after adjusting to age of diagnosis, stage of disease, sex of patients, and Breslow depth of the tumors. This evidence concerns the gene AR and cutaneous melanoma.